课题基金 / 基金详情

HCV founder viruses as vaccine targets

HCV founder viruses as vaccine targets
HCV 创始人病毒作为疫苗目标
批准号：
nhmrc : 1042090
负责人：
A/Pr Fabio Luciani
金额：
$34.73万
依托单位：
The University of New South Wales
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2013
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2013-01-01 至 2015-12-31
来源：
https://researchdata.edu.au/hcv-founder-viruses-vaccine-targets/111435
关键词：
HCVfoundervirusesvaccinetargets

项目摘要

项目成果

A/Pr Fabio Luciani的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Most individuals infected with hepatitis C virus (HCV) develop progressive liver disease. A vaccine is urgently needed, and needs to mimic the immune responses seen in the minority of individuals who clear infection. However, there are large gaps in our understanding of these responses as most acute infections cause no illness and pass unnoticed. This project will fill these gaps by detailed immunological and virological analysis of a large group of subjects with early infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Systems immunology of antigen specific T cells: from single-cell to immune protection
  • 批准号：
    nhmrc : 1128416
  • 项目类别：
    Career Development Fellowships
  • 资助金额：
    $32.12万
  • 财政年份：
    2017
  • 负责人：
    A/Pr Fabio Luciani
  • 依托单位：
    The University of New South Wales
Determining the unique processes that control memory B cell-mediated secondary antibody responses
  • 批准号：
    nhmrc : GNT1124681
  • 项目类别：
    Project Grants
  • 资助金额：
    $85.36万
  • 财政年份：
    2017
  • 负责人：
    A/Pr Fabio Luciani
  • 依托单位：
Determining the unique processes that control memory B cell-mediated secondary antibody responses
  • 批准号：
    nhmrc : 1124681
  • 项目类别：
    Project Grants
  • 资助金额：
    $58.34万
  • 财政年份：
    2017
  • 负责人：
    A/Pr Fabio Luciani
  • 依托单位：
    Garvan Institute of Medical Research
The phenotype of protective cytotoxic T cell responses during viral infections
  • 批准号：
    nhmrc : GNT1121643
  • 项目类别：
    Project Grants
  • 资助金额：
    $84.11万
  • 财政年份：
    2017
  • 负责人：
    A/Pr Fabio Luciani
  • 依托单位：
海外基金